申请人:Kowa Co., Ltd.
公开号:US06653334B1
公开(公告)日:2003-11-25
The present invention is directed to a benzoxazole compound represented by the following formula (1):
(wherein R1 represents an alkyl group, a C6-10 aryl-C1-8 alkyl group, etc.; each of R2 and R3, which are identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; and n represents a number of 1 to 3) or a salt thereof and to a pharmaceutical compound containing the same. These compounds electively activate PPAR&agr;.
本发明涉及一种由以下式(1)表示的苯并噁唑化合物:(其中R1代表烷基,C6-10芳基-C1-8烷基等;R2和R3分别相同或不同,代表氢原子、甲基或乙基基团;n代表1到3的数字)或其盐,以及含有该化合物的药物化合物。这些化合物选择性激活PPAR&agr;。